Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients
Clinical trial NCT04803955 · UNKNOWN
Trial details
- NCT number
- NCT04803955
- Sponsor
- Tianjin Chasesun Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-15
- Primary completion
- 2024-05-30
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.